MindBio Therapeutics Leverages AI Voice Analysis for Scalable Intoxication Detection

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing its AI-powered voice analysis technology as a scalable alternative to traditional intoxication testing methods, according to a recent TechMediaWire Podcast featuring CEO Justin Hanka. The company has built prediction models using over 50 million data points collected through years of clinical research, enabling the identification of intoxication indicators associated with alcohol and drug use through non-invasive speech assessment.

During the podcast, Hanka outlined the technology's potential to replace biological sample testing in safety-sensitive industries such as mining, aviation, construction, and law enforcement. The company is developing enterprise deployment systems that combine proprietary software with Edge-AI kiosks capable of delivering assessments in less than three seconds. Live workplace testing is expected to begin during the second quarter of 2026.

MindBio's approach leverages voice analysis to detect intoxication, which could offer faster and more convenient testing compared to breathalyzers or urine tests. The company believes its technology addresses the need for scalable solutions that can be deployed across large workforces without the logistical challenges of sample collection and analysis.

Beyond workplace impairment detection, MindBio sees broader opportunities for AI-driven voice analytics as a diagnostic tool for identifying physiological and neurological conditions. This aligns with the company's position as a biotechnology firm commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy.

MindBio is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for detection in various enterprise environments. The company's technology could potentially be applied in other sectors where rapid, non-invasive testing is valuable.

For more details on the podcast and MindBio's technology, visit https://ibn.fm/HJarm. The latest news and updates relating to MBQIF are available in the company's newsroom at https://ibn.fm/MBQIF.